RPL23AP53 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.253000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.404800E-01
Normal-vs-Stage2
1.650990E-01
Normal-vs-Stage3
4.455700E-02
Normal-vs-Stage4
7.381600E-01
Stage1-vs-Stage2
1.171380E-01
Stage1-vs-Stage3
1.312620E-01
Stage1-vs-Stage4
5.917600E-01
Stage2-vs-Stage3
3.602800E-01
Stage2-vs-Stage4
2.808100E-02
Stage3-vs-Stage4
1.147970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.411800E-01
Normal-vs-AfricanAmerican
3.160200E-01
Normal-vs-Asian
3.686000E-02
Caucasian-vs-AfricanAmerican
7.275200E-01
Caucasian-vs-Asian
1.061380E-01
AfricanAmerican-vs-Asian
1.451010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.283600E-01
Normal-vs-Female
2.293800E-01
Male-vs-Female
3.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.436200E-01
Normal-vs-Age(41-60Yrs)
3.413600E-01
Normal-vs-Age(61-80Yrs)
2.168400E-01
Normal-vs-Age(81-100Yrs)
3.233700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.175800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.877600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.063400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.580400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.462440E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.165800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.115410E-01
Normal-vs-Daily Drinker
1.243340E-04
Normal-vs-Weekly Drinker
6.297600E-01
Normal-vs-Occasional Drinker
7.408200E-02
Normal-vs-Social Drinker
7.288600E-01
Non Drinker-vs-Daily Drinker
8.477600E-02
Non Drinker-vs-Weekly Drinker
7.561600E-02
Non Drinker-vs-Occasional Drinker
8.610800E-01
Non Drinker-vs-Social Drinker
6.790100E-02
Daily Drinker-vs-Weekly Drinker
7.884400E-03
Daily Drinker-vs-Occasional Drinker
6.210400E-02
Daily Drinker-vs-Social Drinker
1.139830E-02
Weekly Drinker-vs-Occasional Drinker
1.091760E-01
Weekly Drinker-vs-Social Drinker
9.119600E-01
Occasional Drinker-vs-Social Drinker
1.332840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.937400E-01
Normal-vs-Grade 2
2.905800E-01
Normal-vs-Grade 3
3.543600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.016800E-01
Grade 1-vs-Grade 3
9.220200E-01
Grade 1-vs-Grade 4
4.937400E-01
Grade 2-vs-Grade 3
9.768000E-01
Grade 2-vs-Grade 4
2.905800E-01
Grade 3-vs-Grade 4
3.543600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.069000E-01
Normal-vs-NonDiabetic
1.702620E-01
Diabetic-vs-NonDiabetic
7.348600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.043000E-03
Normal-vs-NoPancreatitis
2.301200E-01
Pancreatitis-vs-NoPancreatitis
3.335800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.311000E-01
Normal-vs-N1
1.807800E-01
N0-vs-N1
9.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.516100E-02
Normal-vs-TP53-NonMutant
1.989410E-01
TP53-Mutant-vs-TP53-NonMutant
1.763210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
